Fred B. Davenport Jr., President at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 80,000 shares at $36.50 ($2.9M) on 2006-05-22, disclosed to the SEC on 2006-05-23.
Open-market sale of $2.9M PPDI by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.40 | 12,500 | $455K | 15.6% |
| 2 | $36.44 | 20,000 | $729K | 25.0% |
| 3 | $36.46 | 12,500 | $456K | 15.6% |
| 4 | $36.49 | 10,000 | $365K | 12.5% |
| 5 | $36.50 | 5,000 | $183K | 6.3% |
| 6 | $36.50 | 12,500 |
| $456K |
| 15.6% |
| 7 | $36.62 | 7,500 | $275K | 9.4% |
| Total | $36.47 avg | 80,000 | $2.9M | 100% |
| Filing → |
| MEDP | SELL | 2025-04-28 | $1.0M | — | Filing → |
| MEDP | BUY | 2022-02-22 | $73K | — | Filing → |
| PPDI | SELL | 2006-12-19 | $2.2M | — | Filing → |